Wet-dry-wet drug screen leads to the synthesis of TS1, a novel compound reversing lung fibrosis through inhibition of myofibroblast differentiation
Source check: Needs source check. Not independent scientific confirmation.
Finding: ML analysis of an earlier fibroblast screen virtually screened millions of compounds; synthesised dopamine-related hits including TS1 inhibited myofibroblast activation ex vivo and reversed fibrosis in the reported models.
Technology: Machine-learning virtual screen trained on HTS data
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- Virtual screening nominated compounds.
- Test and result
- Ex vivo validation per abstract.
- Limitation / still unknown
- Preclinical only.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://europepmc.org/search?query=DOI:10.1038/s41419-021-04439-4
Needs source check · editorial details
The source has not been fully checked or contains conflicting information. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 17 Nov 2026. Review scope: Europe PMC metadata and abstract only; Methods not read..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.